Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 By: ACCESSWIRE May 08, 2024 at 04:30 AM EDT BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2024, after the close of the financial markets on Wednesday, May 15, 2024. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Wednesday, May 15 at 4:30 PM ET to review results. Conference Details:Conference Date: Wednesday, May 15, 2024Conference Time: 4:30 PM ETConference dial-in: 877-545-0523International dial-in: 973-528-0016Passcode: 693614Conference Call Name: Xtant Medical Q1 2024 Financial ResultsWebcast Link: https://www.webcaster4.com/Webcast/Page/3039/50597 Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor Info." About Xtant Medical Holdings, Inc. Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers. The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners. Investor Relations Contact Brett Maas • Managing Partner, Hayden IR brett@haydenir.com • (646) 536-7331 SOURCE: Xtant Medical Holdings, Inc. View the original press release on accesswire.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 By: ACCESSWIRE May 08, 2024 at 04:30 AM EDT BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2024, after the close of the financial markets on Wednesday, May 15, 2024. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Wednesday, May 15 at 4:30 PM ET to review results. Conference Details:Conference Date: Wednesday, May 15, 2024Conference Time: 4:30 PM ETConference dial-in: 877-545-0523International dial-in: 973-528-0016Passcode: 693614Conference Call Name: Xtant Medical Q1 2024 Financial ResultsWebcast Link: https://www.webcaster4.com/Webcast/Page/3039/50597 Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor Info." About Xtant Medical Holdings, Inc. Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers. The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners. Investor Relations Contact Brett Maas • Managing Partner, Hayden IR brett@haydenir.com • (646) 536-7331 SOURCE: Xtant Medical Holdings, Inc. View the original press release on accesswire.com
BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2024, after the close of the financial markets on Wednesday, May 15, 2024. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Wednesday, May 15 at 4:30 PM ET to review results. Conference Details:Conference Date: Wednesday, May 15, 2024Conference Time: 4:30 PM ETConference dial-in: 877-545-0523International dial-in: 973-528-0016Passcode: 693614Conference Call Name: Xtant Medical Q1 2024 Financial ResultsWebcast Link: https://www.webcaster4.com/Webcast/Page/3039/50597 Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor Info." About Xtant Medical Holdings, Inc. Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers. The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners. Investor Relations Contact Brett Maas • Managing Partner, Hayden IR brett@haydenir.com • (646) 536-7331 SOURCE: Xtant Medical Holdings, Inc. View the original press release on accesswire.com